IL198169A0 - Robust sustained release formulations of oxymorphone - Google Patents

Robust sustained release formulations of oxymorphone

Info

Publication number: IL198169A0
Authority: IL; Israel
Prior art keywords: oxymorphone; sustained release; release formulations; robust sustained; robust
Prior art date: 2006-10-10

Application number

IL198169A

Original Assignee

Penwest Pharmaceuticals Compan

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-10

Filing date

2009-04-16

Publication date

2009-12-24

2009-04-16 Application filed by Penwest Pharmaceuticals Compan filed Critical Penwest Pharmaceuticals Compan

2009-12-24 Publication of IL198169A0 publication Critical patent/IL198169A0/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Pain & Pain Management (AREA)
Chemical Kinetics & Catalysis (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IL198169A 2006-10-10 2009-04-16 Robust sustained release formulations of oxymorphone IL198169A0 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US2006/039767 WO2008045046A1 (en)	2006-10-10	2006-10-10	Robust sustained release formulations of oxymorphone

Publications (1)

Publication Number	Publication Date
IL198169A0 true IL198169A0 (en)	2009-12-24

Family

ID=38169509

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL198169A IL198169A0 (en)	2006-10-10	2009-04-16	Robust sustained release formulations of oxymorphone

Country Status (10)

Country	Link
EP (1)	EP2097069A1 (en)
JP (1)	JP2010505947A (en)
KR (1)	KR20090076946A (en)
CN (1)	CN101578095A (en)
AU (1)	AU2006349471A1 (en)
BR (1)	BRPI0621952A2 (en)
CA (1)	CA2652980A1 (en)
IL (1)	IL198169A0 (en)
MX (1)	MX2009003772A (en)
WO (1)	WO2008045046A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20030034171A (en)	2001-07-06	2003-05-01	엔도 파마슈티걸즈, 인크.	Oxymorphone controlled release formulations
BRPI0621951A2 (en) *	2006-10-10	2011-10-18	Penwest Pharmaceuticals Co	FORMULATIONS WITH PROLONGED RELEASE OF OXYMORPHONE AND DOSAGE FORMS
EP3473246A1 (en)	2017-10-19	2019-04-24	Capsugel Belgium NV	Immediate release abuse deterrent formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL208484B1 (en) *	2001-07-06	2011-05-31	Penwest Pharmaceuticals Company	Methods of making sustained release formulations of oxymorphone related applications
KR20030034171A (en) *	2001-07-06	2003-05-01	엔도 파마슈티걸즈, 인크.	Oxymorphone controlled release formulations
AU2002337686B2 (en) *	2001-09-26	2008-05-15	Penwest Pharmaceuticals Company	Opioid formulations having reduced potential for abuse
BRPI0621951A2 (en) *	2006-10-10	2011-10-18	Penwest Pharmaceuticals Co	FORMULATIONS WITH PROLONGED RELEASE OF OXYMORPHONE AND DOSAGE FORMS

2006
- 2006-10-10 CN CNA2006800560524A patent/CN101578095A/en active Pending
- 2006-10-10 EP EP06816745A patent/EP2097069A1/en not_active Withdrawn
- 2006-10-10 CA CA002652980A patent/CA2652980A1/en not_active Abandoned
- 2006-10-10 BR BRPI0621952-7A patent/BRPI0621952A2/en not_active Application Discontinuation
- 2006-10-10 KR KR1020097008716A patent/KR20090076946A/en not_active Application Discontinuation
- 2006-10-10 WO PCT/US2006/039767 patent/WO2008045046A1/en active Application Filing
- 2006-10-10 JP JP2009532329A patent/JP2010505947A/en active Pending
- 2006-10-10 AU AU2006349471A patent/AU2006349471A1/en not_active Abandoned
- 2006-10-10 MX MX2009003772A patent/MX2009003772A/en not_active Application Discontinuation
2009
- 2009-04-16 IL IL198169A patent/IL198169A0/en unknown

Also Published As

Publication number	Publication date
JP2010505947A (en)	2010-02-25
EP2097069A1 (en)	2009-09-09
AU2006349471A1 (en)	2008-04-17
CA2652980A1 (en)	2008-04-17
MX2009003772A (en)	2009-07-22
CN101578095A (en)	2009-11-11
WO2008045046A1 (en)	2008-04-17
KR20090076946A (en)	2009-07-13
BRPI0621952A2 (en)	2011-10-18

Publication	Publication Date	Title
IL198168A0 (en)	2009-12-24	Robust sustained release formulations
PL2402005T3 (en)	2021-11-22	Sustained release formulations of nalbuphine
IL216401A0 (en)	2011-12-29	Sustained release of antinfectives
GB2435419B (en)	2008-03-05	Formulations
IL184460A0 (en)	2007-10-31	Sustained release pharmaeutical formulations
EP2046930A4 (en)	2012-06-27	Rhamnolipid-based formulations
EP2090300A4 (en)	2010-02-10	Sustained release preparation
HK1200092A1 (en)	2015-07-31	Sustained release formulations
GB0605780D0 (en)	2006-05-03	Formulations
EP1895991A4 (en)	2012-11-07	Modified release formulations of anti-irritability drugs
GB0618697D0 (en)	2006-11-01	Formulations
EP2001400A4 (en)	2013-01-23	Oral formulations of glycyl-2-methylprolyl-glutamate
EP1976488A4 (en)	2010-02-10	Sustained release compositions of alfuzosin
ZA200810178B (en)	2009-12-30	Pharmaceutical compositions for sustained release of phenyephrine
GB0610336D0 (en)	2006-07-05	Formulations
GB0615108D0 (en)	2006-09-06	Novel formulations
EP1871348A4 (en)	2012-08-01	Sustained release pharmaceutical compositions
IL198170A0 (en)	2009-12-24	Robust sustained release formulations of oxymorphone and methods of use thereof
IL198169A0 (en)	2009-12-24	Robust sustained release formulations of oxymorphone
EP2000152A4 (en)	2013-01-23	Solid preparation having improved solubility
GB0718404D0 (en)	2007-10-31	Formulations
ZA200807682B (en)	2009-11-25	Novel formulations
ZA200902096B (en)	2010-09-29	Robust sustained release formulations
GB0722040D0 (en)	2007-12-19	Sustained release methotrexate formulations and methods of use thereof
IL178378A0 (en)	2007-02-11	Extended release pharmaceutical compositions